Pramipexole for the treatment of restless legs syndrome

Expert Opinion on Pharmacotherapy
Clete A Kushida

Abstract

Restless legs syndrome (RLS) is a common disorder that is estimated to affect 10% of Americans. However, it remains largely undiagnosed and untreated by clinicians. The primary symptoms of this condition are leg discomfort or an urge to move that is temporarily relieved by movement and is worse at rest and at bedtime. RLS impacts the quality of life of the sufferer by disrupting sleep and disturbing or curtailing work and social activities. Approximately 80% of RLS sufferers also have periodic limb movements during sleep, in which repetitive leg movements fragment sleep and may result in daytime drowsiness. RLS may be treated by dopaminergic agents, benzodiazepines, anticonvulsants and opiates; dopamine agonists are currently considered first-line therapy for this condition. Pramipexole has been studied in the treatment of RLS since 1998. This article reviews the role of this medication in the management of this serious neurological disorder.

References

Sep 1, 1995·Movement Disorders : Official Journal of the Movement Disorder Society·A S Walters
Jan 1, 1997·Movement Disorders : Official Journal of the Movement Disorder Society·J MontplaisirP Lespérance
Apr 16, 1998·Movement Disorders : Official Journal of the Movement Disorder Society·J MontplaisirG Lavigne
Jun 11, 1998·Mayo Clinic Proceedings·S C LinP A Fredrickson
Apr 2, 1999·Neurology·J MontplaisirB Gomez-Mancilla
Mar 25, 2000·Journal of Sleep Research·D B RyeP Gurecki
May 18, 2000·Archives of Neurology·E K Tan, W Ondo
Oct 29, 2000·European Journal of Neurology : the Official Journal of the European Federation of Neurological Societies·J MontplaisirD Petit
Dec 5, 2000·Journal of Neuroscience Research·C J EarleyJ R Connor
Feb 24, 2001·Psychiatry and Clinical Neurosciences·T KageyamaT Takemoto
Jun 8, 2001·Movement Disorders : Official Journal of the Movement Disorder Society·E K TanK K Koh
Feb 2, 2002·JAMA : the Journal of the American Medical Association·Douglas E HobsonJonathan Fleming
Sep 21, 2002·European Archives of Psychiatry and Clinical Neuroscience·M SaletuB Saletu
Nov 1, 2002·Clinical Neuropharmacology·G S BleuminkB H Ch Stricker
Nov 1, 2003·Sleep Medicine·L Ferini-Strambi
Nov 1, 2003·Sleep Medicine·Arthur S WaltersUNKNOWN International Restless Legs Syndrome Study Group
Dec 6, 2003·Sleep·Michael H SilberRicardo Izurieta
Jan 17, 2004·Sleep Medicine·John W Winkelman, Lindsay Johnston
Feb 27, 2004·Brain : a Journal of Neurology·K Stiasny-KolsterR-D Treede
May 29, 2004·Sleep·Michael R LittnerUNKNOWN Standards of Practice Committee of the American Academy of Sleep Medicine
May 29, 2004·Sleep·Wayne A HeningUNKNOWN Restless Legs Syndrome Task Force of the Standards of Practice Committee of the American Academy of Sleep Medicine
May 29, 2004·Sleep Medicine·Luigi Ferini-StrambiGiorgio Casari
Jul 13, 2004·Mayo Clinic Proceedings·Michael H SilberUNKNOWN Medical Advisory Board of the Restless Legs Syndrome Foundation
Feb 1, 2005·Sleep Medicine·G M RosenM W Mahowald
Jul 13, 2005·Archives of Neurology·M Leann DoddJ Eric Ahlskog
Aug 12, 2005·Mayo Clinic Proceedings·E Andrew WallerMichael G Heckman

❮ Previous
Next ❯

Citations

Sep 8, 2012·Therapeutics and Clinical Risk Management·Philippe Corcia, Paul H Gordon
Feb 27, 2009·Clinical Drug Investigation·S ChiechioF Nicoletti
Aug 10, 2007·Expert Opinion on Pharmacotherapy·Roland Staud
Oct 6, 2012·Sleep Medicine·Melissa C Lipford, Michael H Silber
Feb 3, 2007·Movement Disorders : Official Journal of the Movement Disorder Society·Claudia TrenkwalderUNKNOWN CALDIR Study Group
Oct 21, 2010·Journal of Clinical Pharmacology·Michael E BozikEvan W Ingersoll

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.